ITMI921556A0 - Farmaco contenente melatonina e/o agonisti, con somministrazione particolarmente efficace nelle patologie che interferiscono con i ritmi circadiani - Google Patents

Farmaco contenente melatonina e/o agonisti, con somministrazione particolarmente efficace nelle patologie che interferiscono con i ritmi circadiani

Info

Publication number
ITMI921556A0
ITMI921556A0 IT92MI1556A ITMI921556A ITMI921556A0 IT MI921556 A0 ITMI921556 A0 IT MI921556A0 IT 92MI1556 A IT92MI1556 A IT 92MI1556A IT MI921556 A ITMI921556 A IT MI921556A IT MI921556 A0 ITMI921556 A0 IT MI921556A0
Authority
IT
Italy
Prior art keywords
agonists
interfere
diseases
particularly effective
drug containing
Prior art date
Application number
IT92MI1556A
Other languages
English (en)
Inventor
Margherita Borgonovo
Carlo Introini
Franco Franschini
Buyidar Stankov
Original Assignee
Iflo Di Giorgio Ed Aldo Laguzz
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Iflo Di Giorgio Ed Aldo Laguzz filed Critical Iflo Di Giorgio Ed Aldo Laguzz
Priority to ITMI921556A priority Critical patent/IT1254995B/it
Publication of ITMI921556A0 publication Critical patent/ITMI921556A0/it
Priority to JP5152525A priority patent/JPH0672874A/ja
Priority to EP93830270A priority patent/EP0578620B1/en
Priority to DE69330150T priority patent/DE69330150D1/de
Priority to AT93830270T priority patent/ATE200617T1/de
Publication of ITMI921556A1 publication Critical patent/ITMI921556A1/it
Priority to US08/196,380 priority patent/US5552428A/en
Application granted granted Critical
Publication of IT1254995B publication Critical patent/IT1254995B/it

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0014Skin, i.e. galenical aspects of topical compositions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/26Psychostimulants, e.g. nicotine, ***e
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/24Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Epidemiology (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Dermatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
ITMI921556A 1992-06-24 1992-06-24 Farmaco contenente melatonina e/o agonisti, con somministrazione particolarmente efficace nelle patologie che interferiscono con i ritmi circandiani IT1254995B (it)

Priority Applications (6)

Application Number Priority Date Filing Date Title
ITMI921556A IT1254995B (it) 1992-06-24 1992-06-24 Farmaco contenente melatonina e/o agonisti, con somministrazione particolarmente efficace nelle patologie che interferiscono con i ritmi circandiani
JP5152525A JPH0672874A (ja) 1992-06-24 1993-06-24 概日リズム障害疾患用薬剤
EP93830270A EP0578620B1 (en) 1992-06-24 1993-06-24 Pharmaceutical compositions for transdermal delivery of melatonin and/or its analogues
DE69330150T DE69330150D1 (de) 1992-06-24 1993-06-24 Pharmazeutische Zusammensetzungen zur transdermalen Verabreichung von Melatonin und/oder seine Analoge
AT93830270T ATE200617T1 (de) 1992-06-24 1993-06-24 Pharmazeutische zusammensetzungen zur transdermalen verabreichung von melatonin und/oder seine analoge
US08/196,380 US5552428A (en) 1992-06-24 1994-02-15 Compounds effective in the treatment of circadian rhythms and related disorders, the novel pharmaceutical preparations and novel method of application

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ITMI921556A IT1254995B (it) 1992-06-24 1992-06-24 Farmaco contenente melatonina e/o agonisti, con somministrazione particolarmente efficace nelle patologie che interferiscono con i ritmi circandiani

Publications (3)

Publication Number Publication Date
ITMI921556A0 true ITMI921556A0 (it) 1992-06-24
ITMI921556A1 ITMI921556A1 (it) 1993-12-24
IT1254995B IT1254995B (it) 1995-10-11

Family

ID=11363575

Family Applications (1)

Application Number Title Priority Date Filing Date
ITMI921556A IT1254995B (it) 1992-06-24 1992-06-24 Farmaco contenente melatonina e/o agonisti, con somministrazione particolarmente efficace nelle patologie che interferiscono con i ritmi circandiani

Country Status (5)

Country Link
EP (1) EP0578620B1 (it)
JP (1) JPH0672874A (it)
AT (1) ATE200617T1 (it)
DE (1) DE69330150D1 (it)
IT (1) IT1254995B (it)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5591768A (en) * 1990-12-04 1997-01-07 State Of Oregan, Acting By And Through The Oregon State Board Of Higher Education On Behalf Of The Oregon Health Sciences University Methods for treating circadian rhythm phase disturbances
US6638963B1 (en) 1990-12-04 2003-10-28 Oregon Health And Science University Methods for treating circadian rhythm disorders
US5449683A (en) * 1992-10-01 1995-09-12 Massachussetts Institute Of Technology Methods of inducing sleep using melatonin
US5654325A (en) * 1993-11-18 1997-08-05 Eli Lilly And Company Melatonin derivatives for use in treating sleep disorders
US6180657B1 (en) * 1993-11-18 2001-01-30 Eli Lilly And Company Melatonin derivatives for use in treating desynchronization disorders
CA2182700A1 (en) * 1994-03-30 1995-10-12 Irmgard Wiesenberg Screening method using the rzr receptor family
DE19713141A1 (de) * 1996-03-29 1997-10-30 Labtec Gmbh Transdermales System mit Melatonin
FR2754454B1 (fr) * 1996-10-10 1998-11-27 Oreal Utilisation d'au moins un glycol comme agent de solubilisation de la melatonine dans l'eau et compositions obtenues
IT1289939B1 (it) * 1997-02-20 1998-10-19 Angelini Ricerche Spa Composizione farmaceutica acquosa comprendente un principio attivo altamente insolubile in acqua
EP1214944B1 (en) 1999-08-20 2009-09-23 Takeda Pharmaceutical Company Limited Composition for PERCUTANEOUS ABSORPTION with a compound having a melatonin receptor agonist activity
CA2381860C (en) 1999-08-26 2009-11-24 Takeda Chemical Industries, Ltd. Matrix adhering to nasal mucosa
US7884037B2 (en) 2006-12-15 2011-02-08 Kimberly-Clark Worldwide, Inc. Wet wipe having a stratified wetting composition therein and process for preparing same

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6045513A (ja) * 1983-05-18 1985-03-12 モナシユ ユニバ−シテイ 身体行動および機能の日周期の不調を軽減する薬剤
ATE77230T1 (de) * 1985-03-04 1992-07-15 Cell Eng Ag Melatoninhaltige mittel sowie deren verwendungen.
JPS61212512A (ja) * 1985-03-19 1986-09-20 Shiseido Co Ltd 養毛料
JPS61221106A (ja) * 1985-03-28 1986-10-01 Shiseido Co Ltd 皮膚外用剤
GB8517958D0 (en) * 1985-07-16 1985-08-21 Cellena Cell Eng Ag Compositions containing melatonin/homologues
JPH0418034A (ja) * 1990-05-11 1992-01-22 Kanegafuchi Chem Ind Co Ltd 点眼組成物
EP0483077B1 (en) * 1990-09-28 1995-12-06 I.F.L.O. S.a.s. di Giorgio e Aldo Laguzzi A method for carrying out the synthesis of a contraceptive and menstrual cycle controlling drug having oncostatic, antikinetosic, preventive and therapeutic properties for treatment of mammary tumours and melanomas.
EP0518468B1 (en) * 1991-05-09 1999-06-30 Neurim Pharmaceuticals (1991) Limited Melatonin containing compositions
IT1251544B (it) * 1991-05-13 1995-05-17 Gabriele Biella Composizioni farmaceutiche attive nella terapia dei disturbi del sonno comprendenti melatonina o un suo derivato in associazione con un derivato benzodiazepinico
US5508039A (en) * 1991-10-18 1996-04-16 Alza Corporation Controlled transdermal administration of melatonin

Also Published As

Publication number Publication date
IT1254995B (it) 1995-10-11
EP0578620A1 (en) 1994-01-12
DE69330150D1 (de) 2001-05-23
EP0578620B1 (en) 2001-04-18
ATE200617T1 (de) 2001-05-15
JPH0672874A (ja) 1994-03-15
ITMI921556A1 (it) 1993-12-24

Similar Documents

Publication Publication Date Title
NO305886B1 (no) Anvendelse av et organisk nitritt for fremstilling av medikamenter for kontinuerlig, vasodilatorisk terapi
DE3688710D1 (de) Isolierung und pharmazeutische verwendung von hyaluronidase und diese enthaltende pharmazeutische und tieraerztliche praeparate.
IT1199760B (it) Dispositivo terapeutico per la somministrazione di medicamenti
DK0513702T3 (da) Melatoninderivater til anvendelse til behandling af søvnlidelser og til præ-anæstetisk medicinering
ZA928011B (en) Transdermal administration of melatonin.
DE3769707D1 (de) Therapeutisches system mit geregelter wirkstoffabgabe.
ITMI921556A0 (it) Farmaco contenente melatonina e/o agonisti, con somministrazione particolarmente efficace nelle patologie che interferiscono con i ritmi circadiani
DE69309698D1 (de) Hautbehandlung mit adhäsionsverstärkenden eigenschaften
IT8647625A0 (it) Preparati farmaceutici con efficacia analgesica, nonche' loro produzione ed impiego
DE3875866D1 (de) Sulfonamidolphenyl-derivate und diese enthaltende therapeutische und vorbeugend wirkende mittel gegen arrhythmie.
DE68909501D1 (de) Hydroxyalkylcystein-derivate und diese enthaltende expectoranzien.
KR950702112A (ko) 내장 진통 및 편두통의 치료 약물(Medicaments for the treatment of visceral pain and migraine)
FI973185A (fi) Melatoniinin käyttö lääkeriippuvuudesta kärsivien potilaiden hoitoon
ITMI911101A0 (it) Farmaco attivo nelle malattie autoimmunitarie
FR2735132B1 (fr) Medicament polypeptidique modifie, composition et dispositif d'administration par electrotransport le contenant
ITMI921612A0 (it) Farmaco sintetizzato analogo della melatonina particolarmente efficace nelle patologie che interferiscono con i ritmi circadiani
DE69306768D1 (de) Medizinischer oder veterinaerer injektionsapparat
KR950700737A (ko) 기도 염증 및 기도 과잉반응의 치료약품(Medicament for the treatment of airways inflammation and airways hyperresponsiveness)
KR900009029A (ko) 가축병 치료용 약물을 투여하는 장치
NO960545D0 (no) Behandling av skadelige virkninger i forbindelse med administrering av ekstracellulært hemoglobin
NO953003L (no) Anvendelse av ifenprodil og diastereoisomerer derav for fremstilling av medisinske preparater
DK554887D0 (da) Terapeutisk middel samt dets anvendelse
NO941319L (no) System for forbedret topisk levering av medikamenter med öket hudpenetrering
IT1190194B (it) Combinazione di analgesico centrale ed adenina per il trattamento analgesico del corpo umano o animale e composizione farmaceutica che la contiene
ITFI920241A0 (it) Impiego della melatonina nella terapia della sclerosi sistematica, della sarcoidosi ed altro

Legal Events

Date Code Title Description
0001 Granted
TA Fee payment date (situation as of event date), data collected since 19931001

Effective date: 19970624